DESVENLAFAXINE
Substance profile for UNII NG99554ANW, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 125017Substance Identity#
- UNII
- NG99554ANW
- Preferred term
- DESVENLAFAXINE
- Registry number
- 93413-62-8
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C16H25NO2
Structure render from PubChem CID 125017Chemical And Database Identifiers#
- SMILES
- CN(C)CC(C1=CC=C(O)C=C1)C2(O)CCCCC2
- RxCUI
- 734064
- PubChem
- 125017
- NCIt
- C61703
- INN ID
- 8361
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| DESVENLAFAXINE | ACTIVE MOIETY | NG99554ANW | These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, oral Initial U.S. Approval: 2008 | 1 | |
| DESVENLAFAXINE | ACTIVE MOIETY | NG99554ANW | PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3747 | |
| DESVENLAFAXINE | ACTIVE MOIETY | NG99554ANW | PRISTIQ EXTENDED RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 2068 | |
| DESVENLAFAXINE | ACTIVE MOIETY | NG99554ANW | PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 47 | |
| DESVENLAFAXINE | ACTIVE INGREDIENT | NG99554ANW | KHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PERNIX THERAPEUTICS] | 14 | |
| DESVENLAFAXINE | ACTIVE MOIETY | NG99554ANW | KHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PERNIX THERAPEUTICS] | 14 | |
| DESVENLAFAXINE | ACTIVE INGREDIENT | NG99554ANW | DESVENLAFAXINE TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.] | 10 | |
| DESVENLAFAXINE | ACTIVE MOIETY | NG99554ANW | DESVENLAFAXINE TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.] | 10 | |
| DESVENLAFAXINE | ACTIVE MOIETY | NG99554ANW | DESVENLAFAXINE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 10 | |
| DESVENLAFAXINE | ACTIVE INGREDIENT | NG99554ANW | KHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.] | 10 | |
| DESVENLAFAXINE | ACTIVE MOIETY | NG99554ANW | KHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.] | 10 | |
| DESVENLAFAXINE | ACTIVE MOIETY | NG99554ANW | PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [CARDINAL HEALTH] | 10 | |
| DESVENLAFAXINE | ACTIVE MOIETY | NG99554ANW | DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [BRECKENRIDGE PHARMACEUTICAL, INC] | 7 | |
| DESVENLAFAXINE | ACTIVE INGREDIENT | NG99554ANW | DESVENLAFAXINE EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [MACOVEN PHARMACEUTICALS] | 7 | |
| DESVENLAFAXINE | ACTIVE MOIETY | NG99554ANW | DESVENLAFAXINE EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [MACOVEN PHARMACEUTICALS] | 7 | |
| DESVENLAFAXINE | ACTIVE MOIETY | NG99554ANW | PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 1 | |